Welcome to LookChem.com Sign In|Join Free
  • or
(4-Nitro-benzylamino)-acetic acid is a chemical compound with the molecular formula C9H10N2O4. It is a derivative of benzylamine with a nitro group and an acetic acid moiety. (4-Nitro-benzylaMino)-acetic acid is known for its versatile applications in various fields, including organic synthesis, pharmaceuticals, agrochemicals, and analytical chemistry.

1727-14-6

Post Buying Request

1727-14-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1727-14-6 Usage

Uses

Used in Organic Synthesis:
(4-Nitro-benzylamino)-acetic acid is used as a building block in organic synthesis for the preparation of various compounds. Its unique structure allows it to be a valuable intermediate in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (4-Nitro-benzylamino)-acetic acid is used as a key component in the development of new drugs. Its potential as a pharmacological agent has been recognized, with studies suggesting its role in the treatment of various diseases and conditions.
Used in Agrochemical Industry:
(4-Nitro-benzylamino)-acetic acid is also utilized in the agrochemical industry for the synthesis of various agrochemicals, such as pesticides and herbicides. Its ability to form stable derivatives makes it a valuable component in the development of effective agricultural products.
Used in Analytical Chemistry:
In the field of analytical chemistry, (4-Nitro-benzylamino)-acetic acid is used as a reagent for the detection and quantification of certain compounds. Its chemical properties make it suitable for use in various analytical techniques, such as chromatography and spectroscopy.
Overall, (4-Nitro-benzylamino)-acetic acid is a versatile chemical compound with a wide range of applications across different industries, making it an important substance in the fields of chemistry and biology.

Check Digit Verification of cas no

The CAS Registry Mumber 1727-14-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,2 and 7 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1727-14:
(6*1)+(5*7)+(4*2)+(3*7)+(2*1)+(1*4)=76
76 % 10 = 6
So 1727-14-6 is a valid CAS Registry Number.

1727-14-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(4-nitrophenyl)methylamino]acetic acid

1.2 Other means of identification

Product number -
Other names N-(4-Nitrobenzyl)glycin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1727-14-6 SDS

1727-14-6Relevant academic research and scientific papers

N-benzyl residues as the P10 substituents in phosphorus-containing extended transition state analog inhibitors of metalloaminopeptidases

Janiszewska, Kamila,Kafarski, Pawe?,Mucha, Artur,Oszywa, Bartosz,Pawe?czak, Ma?gorzata,Talma, Micha?

, (2020/10/12)

Peptidyl enzyme inhibitors containing an internal aminomethylphosphinic bond system (P(O)(OH)-CH2-NH) can be termed extended transition state analogs by similarity to the corresponding phosphonamidates (P(O)(OH)-NH). Phosphonamidate pseudopeptides are broadly recognized as competitive mechanism-based inhibitors of metalloenzymes, mainly hydrolases. Their practical use is, however, limited by hydrolytic instability, which is particularly restricting for dipeptide analogs. Extension of phosphonamidates by addition of the methylene group produces a P-C-N system fully resistant in water conditions. In the current work, we present a versatile synthetic approach to such modified dipeptides, based on the three-component phospha-Mannich condensation of phosphinic acids, formaldehyde, and N-benzylglycines. The last-mentioned component allowed for simple and versatile introduction of functionalized P10 residues located on the tertiary amino group. The products demonstrated moderate inhibitory activity towards porcine and plant metalloaminopeptidases, while selected derivatives appeared very potent with human alanyl aminopeptidase (Ki = 102 nM for 6a). Analysis of ligand-protein complexes obtained by molecular modelling revealed canonical modes of interactions for mono-metallic alanyl aminopeptidases, and distorted modes for di-metallic leucine aminopeptidases (with C-terminal carboxylate, not phosphinate, involved in metal coordination). In general, the method can be dedicated to examine P10-S10 complementarity in searching for non-evident structures of specific residues as the key fragments of perspective ligands.

Protease inhibitors: Synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4- nitrobenzylsulfonylglycine hydroxamate moieties

Scozzafava, Andrea,Supuran, Claudiu T.

, p. 1858 - 1865 (2007/10/03)

A series of compounds was prepared by reaction of alkyl/arylsulfonyl halides with N-4-nitrobenzylglycine, followed by conversion of the COOH to the CONHOH group, with hydroxylamine in the presence of carbodiimides. Other structurally related compounds were obtained by reaction of N-4- nitrobenzylglycine with aryl isocyanates, arylsulfonyl isocyanates, or benzoyl isothiocyanate, followed by the similar conversion of the COOH into the CONHOH moiety. Another subseries of derivatives was prepared from sulfanilyl- or metanilyl-4-nitrobenzylglycine by reaction with arylsulfonyl isocyanates, followed by conversion of the COOH to the hydroxamate moiety. The new compounds were assayed as inhibitors of four matrix metalloproteinases (MMPs), MMP-1, MMP-2, MMP-8, and MMP-9, and of the Clostridium histolyticum collagenase (ChC). Some of the prepared hydroxamate derivatives proved to be very effective collagenase/gelatinase inhibitors, depending on the substitution pattern at the sulfonamido moiety. Substitutions leading to best inhibitors of MMP-1, a short pocket enzyme, were those involving pentafluorophenylsulfonyl or 3- trifluoromethylphenylsulfonyl moieties at P(1') (K(I)'s of 3-5 nM). For MMP- 2, MMP-8, and MMP-9 (deep-pocket enzymes), best inhibitors were especially those containing long perfluoroalkylsulfonyl and substituted-arylsulfonyl moieties, such as pentafluorophenylsulfonyl, 3- and 4-protected- aminophenylsulfonyl, 3- and 4-carboxyphenylsulfonyl, arylsulfonylureido, or arylsulfonylureidosulfanilyl/metanilyl moieties, at P(1') Bulkier groups in this position, such as 1- and 2-naphthyl, substituted-naphthyl, or quinolin- 8-yl moieties among others, led to less effective MMP/ChC inhibitors. Best ChC inhibitors were again those containing pentafluorophenylsulfonyl or 3- and 4-protected-aminophenylsulfonyl P(1') anchoring groups, suggesting that this protease is also a short-pocket wider-neck one (more similar to MMP-1). This study also proves that the 4-nitrobenzyl moiety is an efficient P(2') anchoring moiety and that sulfonylureido, ureido, or carboxythioureido substitutions at P(1') are also tolerated for obtaining potent sulfonylated amino acid hydroxamate-like MMP/ChC inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1727-14-6